Luis M. Ruilope

Luis M. Ruilope

Ciber Cv
Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 440 publications

Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials.

Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials.

Journal: JAMA cardiology

Published: June 03, 2026

The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes.

The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes.

Journal: Journal of cardiac failure

Published: May 21, 2026

Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).

Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).

Journal: Lancet (London, England)

Published: April 23, 2026

Prognostic significance of the magnitude of the white-coat effect in hypertension.

Prognostic significance of the magnitude of the white-coat effect in hypertension.

Journal: Journal of hypertension

Published: April 17, 2026

Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis.

Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis.

Journal: European heart journal

Published: March 14, 2026

Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and Mortality.

Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and Mortality.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: March 04, 2026

Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality.

Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: February 27, 2026

Patient-profiled treatment responses in a large hypertension trial: a posthoc analysis of the INSIGHT study.

Patient-profiled treatment responses in a large hypertension trial: a posthoc analysis of the INSIGHT study.

Journal: Journal of hypertension

Published: December 29, 2025

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.

Journal: Diabetes, obesity & metabolism

Published: December 23, 2025

Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease.

Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: October 29, 2025

Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk in Chronic Kidney Disease and Type 2 Diabetes.

Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk in Chronic Kidney Disease and Type 2 Diabetes.

Journal: JACC. Heart failure

Published: October 22, 2025

Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis.

Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis.

Journal: Journal of the American College of Cardiology

Published: October 19, 2025

Showing 1-12 of 440

Last Updated: 09/26/2026